SK Bioscience inks deal with CEPI on developing mRNA vaccines ...Middle East

Daily Sun - News
SK Bioscience inks deal with CEPI on developing mRNA vaccines
SEOUL: South Korean drugmaker SK Bioscience Co said Tuesday it has signed a deal to join hands with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop messenger RNA (mRNA) vaccines, reported Yonhap.Under the agreement, SK Bioscience will receive US$140 million for the project from CEPI, an Oslo-based international public-private partnership, and develop mRNA vaccines for the Japanese encephalitis virus and the Lassa fever virus.They will also cooperate in developing various vaccines based on mRNA platform technologies to help less-developed countries deal with possible virus infections in the future.The project is part of CEPI’s global programme to advance the development

Hence then, the article about sk bioscience inks deal with cepi on developing mrna vaccines was published today ( ) and is available on Daily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SK Bioscience inks deal with CEPI on developing mRNA vaccines )

Apple Storegoogle play

Last updated :

Also on site :